These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 25305334

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Drugs targeting structural and nonstructural proteins of the chikungunya virus: A review.
    Wang M, Wang L, Leng P, Guo J, Zhou H.
    Int J Biol Macromol; 2024 Mar; 262(Pt 2):129949. PubMed ID: 38311132
    [Abstract] [Full Text] [Related]

  • 44. Progress for dengue virus diseases. Towards the NS2B-NS3pro inhibition for a therapeutic-based approach.
    Melino S, Paci M.
    FEBS J; 2007 Jun; 274(12):2986-3002. PubMed ID: 17509079
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo.
    Whitby K, Pierson TC, Geiss B, Lane K, Engle M, Zhou Y, Doms RW, Diamond MS.
    J Virol; 2005 Jul; 79(14):8698-706. PubMed ID: 15994763
    [Abstract] [Full Text] [Related]

  • 52. Co-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika, Chikungunya and other arboviruses by targeting the viral envelope.
    Neris RLS, Figueiredo CM, Higa LM, Araujo DF, Carvalho CAM, Verçoza BRF, Silva MOL, Carneiro FA, Tanuri A, Gomes AMO, Bozza MT, Da Poian AT, Cruz-Oliveira C, Assunção-Miranda I.
    Sci Rep; 2018 Jun 28; 8(1):9805. PubMed ID: 29955082
    [Abstract] [Full Text] [Related]

  • 53. Recent advances in human flavivirus vaccines.
    Scherwitzl I, Mongkolsapaja J, Screaton G.
    Curr Opin Virol; 2017 Apr 28; 23():95-101. PubMed ID: 28486135
    [Abstract] [Full Text] [Related]

  • 54. Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.
    Guy B, Guirakhoo F, Barban V, Higgs S, Monath TP, Lang J.
    Vaccine; 2010 Jan 08; 28(3):632-49. PubMed ID: 19808029
    [Abstract] [Full Text] [Related]

  • 55. Synthesis of novel rhodamine type Anthrone Spiro-lactam (ASL) analogues and evaluation of antiviral activity against dengue and chikungunya viruses.
    Darole RS, Bagad PK, Gonnade RG, Alagarasu K, Punekar M, Shukla S, Parashar D, Senthilkumar B.
    Eur J Med Chem; 2023 Dec 05; 261():115849. PubMed ID: 37804768
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Mother-to-Child Transmission of Arboviruses during Breastfeeding: From Epidemiology to Cellular Mechanisms.
    Desgraupes S, Hubert M, Gessain A, Ceccaldi PE, Vidy A.
    Viruses; 2021 Jul 07; 13(7):. PubMed ID: 34372518
    [Abstract] [Full Text] [Related]

  • 60. Dengue virus NS2 and NS4: Minor proteins, mammoth roles.
    Gopala Reddy SB, Chin WX, Shivananju NS.
    Biochem Pharmacol; 2018 Aug 07; 154():54-63. PubMed ID: 29674002
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.